FBXL5 and cancer: We currently do not have an in vivo intestinal/colon model that implicit FBXL5 as a potential therapeutic target for cancer stem cells, although an essential role of FBXL5-mediated cellular iron homeostasis in the maintenance of hematopoietic stem cells has already been reported [52].